Skip to Content


In the US, Ziprasidone (ziprasidone systemic) is a member of the drug class atypical antipsychotics and is used to treat Autism, Bipolar Disorder, Body Dysmorphic Disorder, Obsessive Compulsive Disorder, Paranoid Disorder, Schizoaffective Disorder, Schizophrenia and Tourette's Syndrome.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Neuroleptic agent

Serotonin 5-HT₂-receptor antagonist

Dopamine D2 antagonist

Chemical Names

2H-Indol-2-one, 5-[2-[4-(1,2-benzisotiazol-3-yl)-1-piperazinyl]etyl]-6-chloro-1,3-dihydro-

5-[2-[4-(1,2-benzisotiazol-3-yl)-1-piperazinyl]etyl]-6-chloro-2-indolinone (WHO)

5-{2-[4-(1,2-Benzisotiazol-3-yl)piperazin-1-yl]etyl}-6-chloro-1,3-dihydroindol-2-one (BAN)

Foreign Names

  • Ziprasidonum (Latin)
  • Ziprasidon (German)
  • Ziprasidone (French)
  • Ziprasidona (Spanish)

Generic Names

  • Ziprasidone (OS: BAN, DCF)
  • CP 88059 (IS: Pfizer)
  • Ziprasidone Hydrochloride (OS: USAN, BANM)
  • Ziprasidone Hydrochloride Hydrate (OS: JAN)
  • CP 88059-1 (IS: Pfizer)
  • UNII-JAL53626GG (IS)
  • Ziprasidone Hydrochloride (PH: USP 38)
  • Ziprasidone Hydrochloride Monohydrate (PH: BP 2016)
  • Ziprasidone hydrochloride monohydrate (PH: Ph. Eur. 8)
  • Ziprasidone, chlorhydrate de, monohydraté (PH: Ph. Eur. 8)
  • Ziprasidonhydrochlorid-Monohydrat (PH: Ph. Eur. 8)
  • Ziprasidoni hydrochloridum monohydricum (PH: Ph. Eur. 8)
  • Ziprasidone bisulfate (IS)
  • Ziprasidone Mesylate (OS: USAN)
  • CP 88059-27 (IS)
  • UNII-3X6SAX83JZ (IS)
  • Ziprasidone mesilate (IS)

Brand Names


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.